多种耐药细菌在患有呼吸道疾病的中对动物传播的相关性
Ahmed Samir1, Tarek Mosallam2, Hassan Aboul-Ella1
1Department of Microbiology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt.
Veterinary research communications
|May 8, 2025
概括
可以在鼻子中携带诸如大肠杆菌和金黄色杆菌之类的多药耐药细菌,从而构成动物传染的风险. 这项研究在患病的中发现了这些耐药细菌,突出显示了可能传染给人类的可能性.
科学领域:
- 兽医微生物学 兽医微生物学
- 动物传播疾病 动物传播疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 研究往往忽视了的鼻腔的细菌病原体.
- 焦点已经转移到甲研究,使鼻腔运输研究不足.
- 可以携带具有动物性疾病潜力的细菌,这对公众健康构成关注.
研究的目的:
- 为了研究多种耐药性细菌的鼻腔携带,在有呼吸道疾病的中具有动物感染潜力.
- 识别特定的细菌物种及其耐药性基因.
- 评估作为动物传染病原体的水库的风险.
主要方法:
- 从75只患有呼吸道症状的病收集的鼻子抽样.
- 微生物隔离,鉴定和抗微生物敏感性测试.
- 对特定耐药基因 (ESBL,mecA,vanA/vanB) 的分子研究和SCCmec的类型化.
主要成果:
- 已经确定了大肠杆菌 (36%),肺炎菌 (32%),神奇蛋白质 (26.7%) 和金黄色葡萄球菌 (9.3%) 的流行率.
- 在耐药分离物中检测β-乳酸酶基因 (blaTEM,blaSHV,blaCTX-M-15) 和mecA基因.
- 67.1%的分离物显示出多药性耐药性,在Enterococcus faecalis中发现了vanA基因.
结论:
- 患有呼吸道疾病的可以携带多抗药性动物性传染性细菌.
- 这些发现表明在将耐药性病原体传播给人类方面可能发挥作用.
- 需要进一步的研究来了解传播动态和减轻风险.
更多相关视频
08:46Rapid Diagnosis of Avian Influenza Virus in Wild Birds: Use of a Portable rRT-PCR and Freeze-dried Reagents in the Field
Published on: August 2, 2011
15.6K
09:58Environmental Screening of Aeromonas hydrophila, Mycobacterium spp., and Pseudocapillaria tomentosa in Zebrafish Systems
Published on: December 8, 2017
9.7K
相关概念视频
Viral Recombination
23.1K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.1K
Pneumonia I: Introduction
188
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
188
Viral Mutations
32.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.0K
Pneumonia IV: Management
267
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
267
Pneumonia III: Complications and Assessment
122
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
122
